Guardant Health Inc (GH)
19.28
+0.40
(+2.12%)
USD |
NASDAQ |
May 06, 11:55
Guardant Health Cash from Investing (TTM): 840.25M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 840.25M |
| September 30, 2023 | 247.42M |
| June 30, 2023 | 28.00M |
| March 31, 2023 | 196.23M |
| December 31, 2022 | 149.82M |
| September 30, 2022 | -187.51M |
| June 30, 2022 | -276.18M |
| March 31, 2022 | -76.22M |
| December 31, 2021 | -63.16M |
| September 30, 2021 | -94.14M |
| June 30, 2021 | -61.40M |
| Date | Value |
|---|---|
| March 31, 2021 | -514.02M |
| December 31, 2020 | -617.09M |
| September 30, 2020 | -296.04M |
| June 30, 2020 | -317.12M |
| March 31, 2020 | -312.10M |
| December 31, 2019 | -317.57M |
| September 30, 2019 | -538.62M |
| June 30, 2019 | -478.42M |
| March 31, 2019 | -146.17M |
| December 31, 2018 | -153.03M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-617.09M
Minimum
Dec 2020
840.25M
Maximum
Dec 2023
-141.47M
Average
-187.51M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
| Exact Sciences Corp | 49.68M |
| Illumina Inc | -231.00M |
| Delcath Systems Inc | -19.71M |
| CytoSorbents Corp | -0.9362M |
| Progyny Inc | -200.52M |